Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-label Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy

NCT03570931 is registered in ClinicalTrials.gov with Biojiva LLC as lead sponsor.

NCT NCT03570931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03570931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-label Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy
Lead sponsor
Biojiva LLC
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
November 5, 2018
Completion date
June 30, 2022
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infantile neuroaxonal dystrophy